DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Clinical Study on BiHapro Total Hip System With Different Surface Coatings

Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Osteoarthritis

Phase: N/A

Status: Recruiting

Sponsored by: Biomet, Inc.

Overall contact:
Jose Manuel Tevar, Phone: +34 91 721 63 30, Email: josemanuel.tevar@biomet.es

Summary

This post market study intends to evaluate the safety and the performance of BiHapro Total Hip System with two types of coatings.

The efficacy of the prosthesis will be evaluated comparing the pain, the function and the range of motion measured preoperatively and postoperatively using recognized clinical outcomes Harris Hip Score. The secondary efficacy measurement is based on X-rays to measure the mineral bony thickness in the areas of Gruen zones of the proximal femur.

Clinical Details

Official title: Clinical Study on BiHapro Total Hip System With Different Surface Coatings

Study design: Cohort, Prospective

Primary outcome: Harris Hip Score

Secondary outcome: Radiographic Assessment

Eligibility

Minimum age: N/A. Maximum age: 80 Years. Gender(s): Both.

Criteria:

The patients who are selected for this study must fit the following criteria.

- Candidate for a Total Hip Arthroplasty

- Less than 80 years of age.

- A pre-operative level of pain and function the same as for conventional joint

replacement.

- A likelihood of obtaining relief of pain and improved function.

- Full skeletal maturity.

- Ability to follow instructions.

- Good general health for age.

- Willing to return for follow-up evaluations.

- No bias to sex.

Locations and Contacts

Jose Manuel Tevar, Phone: +34 91 721 63 30, Email: josemanuel.tevar@biomet.es

University Hospital of Aviles, Aviles, Spain; Recruiting
Daniel Hernandez Vaquero, MD
Daniel Hernandez Vaquero, MD, Principal Investigator

University Central Hospital of Asturias, Oviedo, Spain; Recruiting
Jose Paz, MD
Jose Paz, MD, Principal Investigator

Additional Information

Starting date: May 2007
Ending date: May 2015
Last updated: June 18, 2009

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009